H5 Bird Flu Statistics in Canada 2026 | Local Transmission, Risk & Facts

H5 Bird Flu in Canada 2026

H5 bird flu in Canada has moved from a poultry-industry problem to a genuine, if still rare, human health concern since the country recorded its first-ever domestically acquired human case in November 2024. As of 2026, the highly pathogenic avian influenza (HPAI) H5N1 virus has been detected in every province and territory in Canada, has been confirmed in 43 at-risk bird species, and has caused the death or culling of an estimated 17.3 million commercial birds since December 2021, at a cost of roughly $360 million to the Canadian agriculture sector. Despite this scale on the animal-health side, the Public Health Agency of Canada (PHAC) continues to assess the risk to the general Canadian public as low, a position that has held steady even through Canada’s only confirmed human infection — a British Columbia teenager who spent nearly two months in intensive care before making a full recovery.

This report compiles the newest verified statistics on H5 bird flu in Canada for 2026, sourced exclusively from the Public Health Agency of Canada, the Canadian Food Inspection Agency (CFIA), Environment and Climate Change Canada, and the Office of the Auditor General of Canada. It covers the country’s sole human case and its clinical course, the scale of poultry and wild bird outbreaks, the current federal risk assessment, and the government’s much-scrutinized vaccine procurement effort, which recently drew formal criticism in a federal audit. Every figure below comes from official government sources or documented federal audit findings, cross-checked against the most recently published releases.

Interesting Facts: H5 Bird Flu Statistics in Canada 2026

Source: Public Health Agency of Canada; Canadian Food Inspection Agency; Office of the Auditor General of Canada, May 2026 audit; provincial government releases, 2024–2026.

Canada’s bird flu situation in 2026 is best understood as two parallel stories moving at different speeds. On the animal-health side, the virus has become deeply entrenched: every Canadian province and territory has recorded detections, the cumulative bird toll has reached 17.3 million commercial birds since the current outbreak cycle began in December 2021, and the Canadian Food Inspection Agency continues to respond to fresh commercial outbreaks on a near-continuous basis rather than the historically typical spring-and-fall migratory pattern. On the human-health side, the picture remains reassuring but no longer theoretical: Canada’s first-ever domestically acquired human H5N1 infection, confirmed in a British Columbia teenager in November 2024, proved the virus is capable of causing severe illness in a person with no known animal contact, even though the case remained isolated and generated no secondary transmission.

The federal government’s own accountability structures have highlighted a second, less discussed dimension of Canada’s 2026 bird flu response: preparedness execution. A May 2026 report from the Office of the Auditor General found that the Public Health Agency of Canada’s human vaccine procurement effort — intended to protect farmers, veterinarians, and other high-exposure workers — resulted in more than 95% of purchased doses expiring unused by February 2026, after a planning process the audit described as lacking adequate needs analysis at the outset. Together, these findings paint a 2026 picture of a virus that is now a fixture of the Canadian agricultural and wildlife landscape, a public health system that has so far kept human risk low through vigilant surveillance, and a preparedness apparatus still working through the lessons of its first major test.

Canada’s Human H5N1 Case: Clinical Timeline and Outcome

CANADA'S ONLY CONFIRMED HUMAN H5N1 CASE — TIMELINE (2024-2025)
════════════════════════════════════════════════════════════
  Nov 8, 2024    Diagnosis confirmed — 13-year-old, Fraser Health region
  Nov 9, 2024    Admitted to BC Children's Hospital; intubated same week
  Nov 12, 2024   Condition described as critical by BC health officials
  Nov 14, 2024   Daily plasma exchange treatment begins
  Jan 2025       Patient off oxygen, out of ICU, no longer infectious
  Total course   Approximately 2 months of hospitalization and treatment
════════════════════════════════════════════════════════════

Source: British Columbia Ministry of Health, news releases, November 2024; CDC Emerging Infectious Diseases journal, “Highly Pathogenic Avian Influenza A(H5N1) in Wild Birds and a Human, British Columbia, Canada, 2024,” June 2025.

The British Columbia teenager’s case remains, as of 2026, Canada’s only confirmed human H5N1 infection, and its clinical severity is precisely why public health officials continue to monitor the virus closely despite the low overall risk assessment. The patient required maximum respiratory life support, daily plasma exchanges, and a combination antiviral regimen that included a drug sourced specifically from the United States — treatment described by the physician who led her care as involving “basically the maximum amount of respiratory support that we’re able to provide in a modern ICU.” That she made a full recovery after roughly two months of intensive treatment demonstrates both the severity H5N1 can cause in a young, previously healthy person and the value of rapid diagnosis and aggressive supportive care.

Genomic analysis published in the CDC’s Emerging Infectious Diseases journal found the strain that infected the BC teenager, clade 2.3.4.4b genotype D1.1, was closely related to the virus circulating in wild birds during British Columbia’s exceptionally severe fall 2024 poultry outbreak wave, which saw at least 54 infected poultry premises identified in the province by late November 2024 alone. Despite this genetic link to the wider bird outbreak, investigators were never able to determine exactly how the teenager was exposed, since she had no known direct contact with poultry or wildlife — a finding that itself underscores why PHAC continues to advise general caution around dead or visibly sick birds even for people without obvious occupational exposure. Critically, no secondary cases were identified among the patient’s household or her hospital care team, providing reassuring evidence that the virus, at least in this instance, did not acquire the capacity for human-to-human transmission.

Poultry and Commercial Bird Outbreaks in Canada 2026

COMMERCIAL BIRD IMPACT SINCE DECEMBER 2021 (CFIA DATA THROUGH MARCH 2026)
════════════════════════════════════════════════════════════
  Total commercial birds died/culled     ████████████████████████ 17.3 million
  Estimated economic cost                ████████████████████████ $360 million
  Provinces/territories with detections  ████████████████████████ 13 of 13 (100%)
  At-risk bird species affected          ███████████████           43 species
════════════════════════════════════════════════════════════

Source: Canadian Food Inspection Agency, Status of Ongoing Avian Influenza Response by Province; Government of Canada, Environment and Climate Change Canada, Avian Influenza overview page, 2026; CBC News, December 2025.

The scale of Canada’s commercial poultry losses to H5N1 has reached a level the CFIA itself has described as historically unprecedented, with roughly 17.3 million birds dying or being culled since the current global outbreak wave intensified in December 2021 — a toll that spans laying hens, broiler chickens, turkeys, and other domestic poultry across every part of the country. The $360 million estimated cost captures direct losses to farmers and the broader compensation, containment, and biosecurity response infrastructure the CFIA maintains, but does not fully capture the emotional and operational toll on individual poultry producers, many of whom have faced repeated outbreaks on the same premises across multiple migratory seasons.

Recent events illustrate that the crisis has not eased with time: in November and December 2025, a cluster of outbreaks near Listowel, Ontario, resulted in more than 109,000 turkeys being culled across at least eight farms within a few weeks, prompting the CFIA to establish a primary control zone in the area and, notably, to restrict media interviews with its own staff over concerns about harassment directed at agency personnel. British Columbia’s Fraser Valley, historically the epicentre of Canada’s poultry industry and its bird flu outbreaks alike, has seen roughly 5 million birds culled since the province’s first 2022 detection, with more than 50 commercial and backyard flocks infected in the fall 2023–2024 migratory season alone — figures that illustrate why B.C. has also been the site of Canada’s only confirmed human infection to date.

Wild Bird and Mammal Detections in Canada 2026

WILD BIRD & MAMMAL SURVEILLANCE — CANADA (DEC 2021-2026)
════════════════════════════════════════════════════════════
  Provinces/territories with detections    ████████████████████████  13 of 13
  At-risk bird species confirmed           ███████████████           43 species
  Mammal species with confirmed cases      ████████         Skunks, foxes (B.C.)
  Dairy cattle H5N1 cases (Canada)          (none)                    0
════════════════════════════════════════════════════════════

Source: Government of Canada, Avian influenza A(H5N1): Canada’s response, canada.ca; Environment and Climate Change Canada surveillance program; CFIA Status of Ongoing Avian Influenza Response by Province, 2026.

Environment and Climate Change Canada’s expanded wild bird surveillance program, running continuously since December 2021, has confirmed H5N1 in 43 different at-risk bird species and detected the virus in migratory populations across every Canadian province and territory — a level of geographic and species spread that reflects how thoroughly the virus has embedded itself in the country’s wild bird populations rather than remaining confined to isolated outbreak events. In British Columbia specifically, the virus has also been confirmed in small wild mammals including skunks and foxes, illustrating the well-documented tendency of H5N1 to spill over from birds into scavenging or predatory mammal species that come into contact with infected carcasses.

One of the most consequential differences between Canada’s outbreak and the parallel situation in the United States is the complete absence of confirmed H5N1 cases in Canadian dairy cattle. Since March 2024, when HPAI was first detected in American dairy herds, Canadian federal agencies have maintained enhanced surveillance specifically watching for any sign of the same mammalian spillover pattern, and as of 2026, no cases have been reported in Canadian dairy cattle and no evidence of the virus has been found in milk samples. This distinction matters directly for public health risk assessment, since the US dairy cattle outbreak has been linked to a number of human infections among farmworkers there — an exposure pathway that, to date, simply does not exist in Canada.

PHAC Risk Assessment and Public Health Guidance in Canada 2026

PHAC RISK ASSESSMENT LEVELS — H5N1 IN CANADA (2026)
════════════════════════════════════════════════════════════
  General Canadian public                 LOW risk
  People with high-level animal exposure  ELEVATED risk (farmers, vets, cullers)
  Evidence of human-to-human spread       NONE identified
  Evidence of virus adapting to humans    NO current evidence
════════════════════════════════════════════════════════════

Source: Public Health Agency of Canada, Avian influenza A(H5N1): Canada’s response; PHAC, Avian influenza A(H5N1): For health professionals, canada.ca, 2026.

PHAC’s current guidance draws a clear distinction between the general public and higher-exposure groups, a framework that has remained consistent even after Canada’s confirmed human case. For the vast majority of Canadians, the risk of infection from animals is described as low, reflecting the fact that transmission to humans requires fairly close or direct contact with infected birds, their secretions, or heavily contaminated environments — conditions most Canadians simply never encounter. For people with higher-level occupational exposure — commercial poultry workers, veterinarians, wildlife researchers, and cullers involved in outbreak response — PHAC and provincial health authorities recommend specific precautions, including personal protective equipment and monitoring protocols, reflecting their meaningfully elevated risk profile.

Underpinning this entire risk framework is Canada’s legal reporting infrastructure under the International Health Regulations (2005): any confirmed or probable human H5N1 case, regardless of symptom severity, must be reported by provincial or territorial health authorities to PHAC within 24 hours, and PHAC is in turn obligated to notify the World Health Organization. This reporting chain functioned exactly as designed during the November 2024 BC case, allowing rapid confirmatory testing at the National Microbiology Laboratory in Winnipeg and coordinated public communication. PHAC’s official position — that there is no current evidence the virus has developed the ability to spread efficiently between humans — remains the central reassurance underlying the “low risk” assessment, though the agency has been explicit that continued viral evolution in animal populations means this assessment is actively monitored rather than static, an approach that mirrors how Canada’s broader healthcare system continually reassesses capacity pressures, much like the strain increasingly visible in the country’s hospital emergency rooms, where surveillance and rapid response capacity are similarly tested by unpredictable surges in demand.

Vaccine Preparedness and Government Response in Canada 2026

PHAC HUMAN VACCINE PROCUREMENT TIMELINE — 2024-2026
════════════════════════════════════════════════════════════
  Jun 2024   Agency intends to acquire 800,000 doses (no analysis conducted)
  Aug 2024   500,000 doses purchased based on initial estimate
  Feb 2025   Detailed analysis finds only 300,000 doses actually needed
  May 2025 - 41,500 doses delivered (39,200 to provinces/territories,
  Feb 2026   2,300 donated for research)
  Feb 2026   Remaining 95%+ of purchased doses expire, unused
════════════════════════════════════════════════════════════

Source: Office of the Auditor General of Canada, Commissioner of the Environment and Sustainable Development, Report on Avian Influenza, May 2026.

The federal government’s human vaccine procurement effort for at-risk workers has become one of the more closely scrutinized aspects of Canada’s overall bird flu response, following a May 2026 report from the Office of the Auditor General. The audit’s timeline shows the Public Health Agency of Canada committed to acquiring 800,000 doses in June 2024 without having conducted a formal needs analysis, then purchased 500,000 doses two months later based on its own preliminary estimate of at-risk population size. It was not until February 2025 — after the purchase had already been made — that a more rigorous internal analysis determined the actual requirement was closer to 300,000 doses, already well below what had been bought.

The practical result, detailed in the audit, was that only 41,500 doses were ever delivered for actual use — 39,200 distributed to provinces and territories for at-risk workers such as farmers and veterinarians, plus 2,300 donated for research purposes — meaning more than 95% of the originally purchased doses expired unused by February 2026. While PHAC has since obtained financial approval to purchase additional doses if needed, the audit noted the agency had not yet decided whether replenishing the vaccine inventory was necessary as of its publication. This procurement episode does not appear to have compromised human health outcomes to date, since Canada’s sole human case was successfully treated with antivirals rather than prevented through vaccination, but it has become a significant case study in pandemic-preparedness planning discipline — one that sits alongside broader, ongoing conversations about resource allocation across Canada’s public health and clinical care systems, including the persistent strain reflected in the country’s mental health service access gaps, where similarly large gaps between initial planning assumptions and actual delivered capacity have been repeatedly documented.

International Trade and Economic Impact in Canada 2026

CANADIAN POULTRY EXPORT RESTRICTIONS FROM H5N1 — 2025-2026
════════════════════════════════════════════════════════════
  Annual value of poultry exports safeguarded       Over $1 billion
  Countries maintaining active import restrictions  Multiple (Japan, others)
  Restriction basis                                 Primary Control Zones (PCZs)
  Trade impact scope                                Live birds, hatching eggs, meat products
════════════════════════════════════════════════════════════

Source: Canadian Food Inspection Agency, Consolidated List of Restrictions Imposed by Foreign Countries as a Result of Avian Influenza, inspection.canada.ca, 2026.

Canada’s poultry export sector, worth more than $1 billion annually, sits directly exposed to the trade consequences of every new domestic H5N1 detection, since trading partners including Japan apply automatic restrictions tied to the CFIA’s own Primary Control Zone designations. When the virus is confirmed on a farm, the CFIA establishes a PCZ around the affected area, and importing countries — under their own animal health agreements — typically suspend imports of live birds, hatching eggs, and poultry meat products originating from that zone, sometimes extending the restriction to the entire province depending on the specific bilateral agreement in place. The restrictions on Quebec (from September 2025) and Ontario (from October 2025), along with narrower municipal-level restrictions such as those covering North Perth and Amherstburg, illustrate how frequently these trade measures are triggered and lifted as outbreaks emerge and are contained across the country.

This trade dimension explains why the CFIA treats containment and culling as an economic necessity as much as an animal-welfare and public-health measure: every day a PCZ remains in effect represents lost export revenue for producers well beyond the directly affected farm. The agency’s own communications have acknowledged that culling, while difficult, remains one of the most effective tools available for limiting viral spread and amplification, framing the practice explicitly in terms of protecting both public health and the billion-dollar-plus export trade that Canadian poultry producers depend on. As Canada moves through 2026 with outbreaks continuing in provinces like Ontario, the interplay between domestic containment speed and the pace at which international trade restrictions are lifted will remain one of the most consequential economic dimensions of the country’s ongoing response to H5 bird flu.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE